Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionKendall Capital Management
Latest Disclosed Ownership2,996 shares
Latest Disclosed Value $ 1,054,143
Kendall Capital Management reports 0.03% decrease in ownership of AMGN / Amgen Inc.

On April 24, 2026 - Kendall Capital Management filed a 13F-HR form disclosing ownership of 2,996 shares of Amgen Inc. (CH:AMGN) valued at $1,054,143 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 2,997 shares of Amgen Inc.. This represents a change in shares of -0.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F Amgen COM 031162100 2,996 -1 -0.03 1,054 7.55 0.2160
2026-01-16 2025-12-31 13F Amgen COM 031162100 2,997 -20 -0.66 981 15.16 0.2052
2025-11-13 2025-09-30 13F Amgen COM 031162100 3,017 -90 -2.90 851 -1.85 0.1919
2025-07-16 2025-06-30 13F Amgen COM 031162100 3,107 32 1.04 868 -9.50 0.2294
2025-04-25 2025-03-31 13F Amgen COM 031162100 3,075 -15 -0.49 958 19.01 0.2815
2025-02-07 2024-12-31 13F Amgen COM 031162100 3,090 -850 -21.57 805 -36.56 0.2357
2024-11-08 2024-09-30 13F Amgen COM 031162100 3,940 -170 -4.14 1,270 -1.17 0.3920
2024-08-12 2024-06-30 13F Amgen COM 031162100 4,110 -416 -9.19 1,284 -0.16 0.4282
2024-05-10 2024-03-31 13F Amgen COM 031162100 4,526 -95 -2.06 1,287 -3.31 0.4427
2024-01-26 2023-12-31 13F Amgen COM 031162100 4,621 -170 -3.55 1,331 132,900.00 0.5170
2023-10-31 2023-09-30 13F Amgen COM 031162100 4,791 -30 -0.62 1 0.00 0.5710
2023-07-28 2023-06-30 13F Amgen COM 031162100 4,821 350 7.83 1 0.00 0.4690
2023-05-11 2023-03-31 13F Amgen COM 031162100 4,471 -33 -0.73 1 0.00 0.5194
2023-01-30 2022-12-31 13F Amgen COM 031162100 4,504 -60 -1.31 1 -99.90 0.5978
2022-11-02 2022-09-30 13F Amgen COM 031162100 4,564 -25 -0.54 1,029 -7.88 0.5988
2022-07-29 2022-06-30 13F Amgen COM 031162100 4,589 -75 -1.61 1,117 -0.98 0.6152
2022-05-06 2022-03-31 13F Amgen COM 031162100 4,664 140 3.09 1,128 10.81 0.5452
2022-01-28 2021-12-31 13F Amgen COM 031162100 4,524 0 0.00 1,018 5.82 0.4832
2021-11-05 2021-09-30 13F Amgen COM 031162100 4,524 9 0.20 962 -12.62 0.5201
2021-07-30 2021-06-30 13F Amgen COM 031162100 4,515 190 4.39 1,101 2.32 0.6190
2021-05-05 2021-03-31 13F Amgen COM 031162100 4,325 0 0.00 1,076 8.25 0.6657
2021-02-08 2020-12-31 13F Amgen COM 031162100 4,325 -170 -3.78 994 -12.96 0.7250
2020-10-22 2020-09-30 13F Amgen COM 031162100 4,495 -1,175 -20.72 1,142 -14.58 0.9934
2020-07-30 2020-06-30 13F Amgen COM 031162100 5,670 -363 -6.02 1,337 9.32 1.2805
2020-04-27 2020-03-31 13F Amgen COM 031162100 6,033 -1,355 -18.34 1,223 -31.33 1.3839
2020-01-24 2019-12-31 13F Amgen COM 031162100 7,388 55 0.75 1,781 25.51 1.4018
2019-11-12 2019-09-30 13F Amgen COM 031162100 7,333 -205 -2.72 1,419 2.16 1.2539
2019-08-09 2019-06-30 13F Amgen COM 031162100 7,538 -195 -2.52 1,389 -5.45 1.2565
2019-05-08 2019-03-31 13F Amgen COM 031162100 7,733 -90 -1.15 1,469 -3.55 1.3925
2019-02-13 2018-12-31 13F Amgen COM 031162100 7,823 220 2.89 1,523 -3.36 1.5771
2018-10-29 2018-09-30 13F Amgen COM 031162100 7,603 -140 -1.81 1,576 10.29 1.3416
2018-07-27 2018-06-30 13F Amgen COM 031162100 7,743 -26 -0.33 1,429 7.93 1.2622
2018-05-14 2018-03-31 13F Amgen COM 031162100 7,769 60 0.78 1,324 -1.27 1.1476
2018-02-14 2017-12-31 13F Amgen COM 031162100 7,709 7,709 1,341 1.1905
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.